Morepen Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹484.16 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.63 per cent from ₹411.58 crore. This corresponds to a year-on-year *(YoY) growth of 6.93 per cent.
Operating Profit
Operating Profit stands at ₹46.32 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.88 per cent from ₹30.70 crore. This corresponds to a year-on-year *(YoY) growth of 28.17 per cent.
PBDT
PBDT stands at ₹45.81 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.59 per cent from ₹56.97 crore. This corresponds to a year-on-year *(YoY) growth of 14.13 per cent.
Profit Before Tax
Profit Before Tax stands at ₹35.43 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.46 per cent from ₹45.69 crore. This corresponds to a year-on-year *(YoY) growth of 0.62 per cent.
Net Profit
Net Profit stands at ₹27.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 32.99 per cent from ₹41.04 crore. This represents a 3.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Morepen Laboratories Ltd News
Morepen Laboratories Ltd Earnings
- YOY
- QOQ
Morepen Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Morepen Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Morepen Laboratories Ltd Financial Reports
Morepen Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Morepen Labs. | -0.33% | 3.80% | 2.83% | -7.58% | -0.53% | -35.63% |
| Unichem Labs. | 0.15% | 0.34% | -0.01% | 4.90% | -18.13% | -38.99% |
| Panacea Biotec | -0.94% | 2.89% | 13.99% | 25.35% | 20.36% | -22.39% |
| Hikal | 0.02% | 4.41% | 12.92% | 2.17% | -6.05% | -45.89% |
| Kwality Pharma | 2.44% | 16.70% | 31.59% | 59.78% | 138.27% | 125.22% |
| Sai Parenteral's | 1.63% | 1.96% | 0.52% | 20.23% | 20.23% | 20.23% |
| Solara Active | -3.28% | -2.26% | 14.59% | 16.08% | 5.10% | 14.36% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Sushil Suri
WTD & Executive Director : Sanjay Suri
Independent Non Exe. Director : Praveen Kumar Dutt
Independent Non Exe. Director : Ranjit Khattar
Independent Non Exe. Director : Savita
Independent Non Exe. Director : Sharad Jain
Company Secretary : Vipul Kumar Srivastava